Focus on life and health research
NOPAINBIO focusing on the research and development of rapid diagnostic products in the field of life sciences, with a focus on technological creation in the life and health industry, our comprehensive business involves integrated procurement and comprehensive construction services in industries such as medical and health, biopharmaceuticals, disease control and rapid testing, and home health.
The enterprise specializes in the diagnostic industry and has complete qualifications for Class I, II, and III medical devices. It undertakes comprehensive packaging, overall project approval, and wholesale and retail of diagnostic reagents covering a wide range of products such as in vitro diagnostic luminescence, biochemistry, chromatography, and enzyme immunoassay. It provides customized market configurations and diagnostic solutions for cooperative enterprises and hospitals, as well as standard quality control services for all models.
The enterprise community undertakes the construction, purification engineering, layout design, and smart system of hospitals, laboratories, and testing centers, and can fully undertake the construction of medical equipment, experimental instruments, information systems, consumables packaging, etc. for all departments of public hospitals.
NOPAINBIO has strategic partnerships with companies such as ThermoFisher from the United States and Sartorius from Germany. It also has academic and business collaborations with top tier hospitals and institutions such as Wuhan Zhongnan Hospital, Tongji Hospital, Shanghai Changhai Hospital, Shandong University, and Xingtai Disease Control and Prevention Center. In terms of foreign trade, the company's products are exported to countries and regions such as the United States, Western Europe, Belarus, Dubai, Africa, and Southeast Asia. The company has recently collaborated with European companies to develop a storage biochar that can store human blood for a long time without relying on storage conditions. It is expected to provide the most convenient, low-cost, and effective technical product support for tracing unknown new infectious diseases, regular storage, and long-term emergency monitoring specimens in the future.
Focus on life and health research
NOPAINBIO focusing on the research and development of rapid diagnostic products in the field of life sciences, with a focus on technological creation in the life and health industry, our comprehensive business involves integrated procurement and comprehensive construction services in industries such as medical and health, biopharmaceuticals, disease control and rapid testing, and home health.
The enterprise specializes in the diagnostic industry and has complete qualifications for Class I, II, and III medical devices. It undertakes comprehensive packaging, overall project approval, and wholesale and retail of diagnostic reagents covering a wide range of products such as in vitro diagnostic luminescence, biochemistry, chromatography, and enzyme immunoassay. It provides customized market configurations and diagnostic solutions for cooperative enterprises and hospitals, as well as standard quality control services for all models.
The enterprise community undertakes the construction, purification engineering, layout design, and smart system of hospitals, laboratories, and testing centers, and can fully undertake the construction of medical equipment, experimental instruments, information systems, consumables packaging, etc. for all departments of public hospitals.
NOPAINBIO has strategic partnerships with companies such as ThermoFisher from the United States and Sartorius from Germany. It also has academic and business collaborations with top tier hospitals and institutions such as Wuhan Zhongnan Hospital, Tongji Hospital, Shanghai Changhai Hospital, Shandong University, and Xingtai Disease Control and Prevention Center. In terms of foreign trade, the company's products are exported to countries and regions such as the United States, Western Europe, Belarus, Dubai, Africa, and Southeast Asia. The company has recently collaborated with European companies to develop a storage biochar that can store human blood for a long time without relying on storage conditions. It is expected to provide the most convenient, low-cost, and effective technical product support for tracing unknown new infectious diseases, regular storage, and long-term emergency monitoring specimens in the future.
Our Advantages
Technology Research and Development
The company has a strong R & D team and rich technological accumulations. It has taken the lead in obtaining the national invention patent for the lateral flow assay method of blue microspheres in China, which has provided a solid technological foundation for the research and development of new products. The company also has in-depth cooperation on cutting-edge technologies with enterprises such as Thermo Fisher Scientific in the United States and Assurance. By introducing international advanced technologies and concepts, it promotes the internationalization process of the company's products and technologies.
Market Positioning
The company focuses on the research and development as well as application of products for detecting infectious diseases and geriatric diseases, which conforms to the market demands and development trends. In addition, the company has already established a certain brand influence and customer base in both domestic and international markets, providing a strong guarantee for market expansion.
Research Team
The company has brought together technical backbones from prestigious universities such as Shandong University, Harvard University, and West China University of Medical Sciences. The team members have rich professional backgrounds and strong technical capabilities. They are professionally dedicated to the research and development of in vitro diagnostic reagents, the predictive research and development of diagnostic reagents for infectious diseases and emergency diseases, as well as the output of related technologies.
Capital Operation
The company has a stable capital chain and a sound financial management system, which can provide solid financial guarantees for the company's sustainable development and technological innovation.
